background logo image
Episode 184

Research Shows Eating THIS Could Reduce Alzheimer’s Risk

Listen, Watch & Subscribe on:

Watch

Research Shows Eating THIS Could Reduce Alzheimer’s Risk

Listen

About the host

Bret Scher, MD

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Bret Scher, MD

Medical Director, Metabolic Mind and Baszucki Group

Bret is the host of the Metabolic Mind YouTube channel and podcast. He is a board-certified cardiologist, lipidologist, and leading expert in therapeutic uses of metabolic therapies, including ketogenic diets. Prior to joining Baszucki Group, Bret was the medical director at DietDoctor.com, an online platform promoting improving metabolic health through low-carb nutrition, where he was a content creator and medical reviewer. Earlier in his career, he worked as a cardiologist in San Diego. Bret has spent most of his 20-year career as a preventive cardiologist, helping people improve their metabolic health and preventing heart disease using low-carb nutrition and lifestyle interventions. His deep passion for educating the public about the benefits of metabolic therapies grew from his experience with the prevailing medical teaching, which frequently misrepresents nutrition science and undervalues metabolic health. Bret received an MD from The Ohio State University College of Medicine and a BS in Biology from Stanford University. He grew up in San Diego and began competing in triathlons at an early age, which helped fuel his love of health and fitness. He continues to enjoy spending time outdoors mountain biking, swimming, hiking, and playing baseball with his two boys.
Learn more about Bret

Key Highlights

  • Carrying one copy of the ApoE4 gene raises Alzheimer’s risk two to three times, and two copies raise it eight to 12 times, but that risk isn’t destiny, since many carriers never develop the disease.
  • In some traditional or non-industrialized populations, ApoE4 doesn’t appear to carry the same elevated Alzheimer’s risk and is even linked to greater longevity, suggesting environment and lifestyle strongly shape how the gene expresses itself.
  • A study in JAMA Network Open found that among ApoE4 carriers, higher meat consumption was associated with lower dementia risk, directly challenging the common advice for ApoE4 carriers to avoid red meat.
  • A separate observational study found vegetarians had a 28% higher dementia risk and vegans a 33% higher risk compared to omnivores, with stricter plant-based eating linked to greater risk in a dose-dependent pattern.
  • Meat provides highly bioavailable nutrients important for brain health, like B12, iron, zinc, and creatine, which are harder to get in adequate amounts from plant-only diets, offering a possible explanation for these findings.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

The Alzheimer’s Antidote, by Amy Berger
Resources

The Alzheimer’s Antidote, by Amy Berger

Amy Berger’s research shows that Alzheimer’s results from a fuel shortage in the brain.

Read more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
News

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals…

Learn more

Keto For Alzheimer’s: A Treatment Whose Time Has Come
Podcast

Keto For Alzheimer’s: A Treatment Whose Time Has Come

In this Metabolic Mind episode, nutritionist and author Amy Berger (“The Alzheimer’s Antidote”) breaks down why Alzheimer’s is increasingly viewed as “type III diabetes” and a problem of brain energy shortage. She explains how ketogenic diets, MCT oil, and exogenous ketones can help fuel insulin-resistant neurons, support mitochondrial health, and potentially improve cognition in people with mild cognitive impairment or Alzheimer’s disease. Amy also critiques microbiome-focused research, highlights the central role of metabolic health (insulin, triglycerides, weight), and offers practical perspective on using nutritional ketosis as a hopeful, science-based strategy for dementia prevention and treatment.

Learn more

The Alzheimer’s Antidote, by Amy Berger
Resources

The Alzheimer’s Antidote, by Amy Berger

Amy Berger’s research shows that Alzheimer’s results from a fuel shortage in the brain.

Read more

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health
Podcast

New Alzheimer’s Trial Reveals Surprising Insight on Brain Health

A new clinical trial reveals semaglutide does not improve cognition in Alzheimer’s disease, challenging earlier observational findings. This highlights the complexity of dementia and suggests metabolic improvements from drugs alone may not be enough. Emerging research points to ketogenic therapy as a promising approach, offering the brain an alternative fuel source when glucose metabolism is impaired.

Learn more

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
News

Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers

SAN MATEO, Calif.–(BUSINESS WIRE)–Baszucki Group today announced an expanded commitment to the landmark Cleveland Clinic Brain Study. Launched in 2022, this ambitious longitudinal study plans to follow healthy individuals…

Learn more

Keto For Alzheimer’s: A Treatment Whose Time Has Come
Podcast

Keto For Alzheimer’s: A Treatment Whose Time Has Come

In this Metabolic Mind episode, nutritionist and author Amy Berger (“The Alzheimer’s Antidote”) breaks down why Alzheimer’s is increasingly viewed as “type III diabetes” and a problem of brain energy shortage. She explains how ketogenic diets, MCT oil, and exogenous ketones can help fuel insulin-resistant neurons, support mitochondrial health, and potentially improve cognition in people with mild cognitive impairment or Alzheimer’s disease. Amy also critiques microbiome-focused research, highlights the central role of metabolic health (insulin, triglycerides, weight), and offers practical perspective on using nutritional ketosis as a hopeful, science-based strategy for dementia prevention and treatment.

Learn more